Optimizing Care for Metastatic Non-Small Cell Lung Cancer Without Driver Mutations
A panel of experts discuss the value of biomarker testing for non-small cell lung cancer without driver mutations and strategies to optimize the outcomes of targeted therapies.
About AJMC® Videos
AJMC®'s video programming features dynamic and informative expert interviews, multi-stakeholder panels and more, all designed to educate and inform managed care professionals and decision-makers.
In-depth interviews with decision-makers, stakeholders, and researchers on timely and emerging trends in clinical data, health policy, value-based care, and more.
Full-size panel discussions featuring expert insights, opinions, and perspectives on key issues facing today’s payers, providers, and patients.
Comprehensive resource hubs that include guideline summaries and expert insights focused on individual clinical practice guidelines.
Small group conversations with payers, administrators, and other key decision-makers on issues relating to practice and policy.
Reactions and commentary on breaking clinical and health economic data presented at top conferences and their impact on practice and policy.
Expert interchange breaking down topics in disease management with a focus on value, equitable care, health policy, and more.
Expert interviews conducted by the AJMC® editorial team, covering timely topics from clinical research to care delivery.
Expert interviews conducted by the AJMC® editorial team, covering timely topics from clinical research to care delivery.
